輸入代號或公司名稱後按 Enter
4161

聿新科

-0.05 (-0.22%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
22.2520成交張數12.32本益比1.35股價淨值比3.14%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入2025837年增 -3.3%
毛利率202529.1%最新一期
營業利益率20258.0%最新一期
每股盈餘20251.23年增 -33.2%
會計項目走勢2016201720182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計70.5%75.9%75.7%73.8%82.9%77.8%76.9%71.1%69.0%70.9%
營業毛利(毛損)29.5%24.1%24.3%26.2%17.1%22.2%23.1%28.9%31.0%29.1%
營業毛利(毛損)淨額29.5%24.1%24.3%26.2%17.1%22.2%23.1%28.9%31.0%29.1%
營業費用合計25.8%23.1%23.9%26.5%25.8%17.3%18.0%18.1%20.6%21.1%
營業利益(損失)3.7%1.0%0.4%-0.3%-8.7%4.8%5.1%10.9%10.4%8.0%
稅前淨利(淨損)2.0%-8.4%6.1%-0.1%-13.1%2.7%8.2%12.9%12.7%10.2%
所得稅費用(利益)合計0.9%-0.7%1.7%-0.1%-0.3%-0.1%2.1%2.6%2.1%1.8%
繼續營業單位本期淨利(淨損)1.0%-7.7%4.4%0.0%-12.8%2.8%6.1%10.2%10.7%8.3%
本期淨利(淨損)1.0%-7.7%4.4%0.0%-12.8%2.8%6.1%10.2%10.7%8.3%
本期綜合損益總額-1.3%-4.9%6.3%-3.7%-0.8%-3.8%4.9%8.4%12.8%8.8%
母公司業主(淨利∕損)1.6%-7.1%5.1%0.9%-12.4%3.1%6.3%10.3%10.8%8.5%
基本每股盈餘0.0%-0.1%0.1%0.0%-0.3%0.1%0.1%0.2%0.2%0.1%
已實現銷貨(損)益0.0%0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。